Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.

Authors:
Moug SJ; Barry SJE; Maguire S; Johns N; Dolan D and 5 more

Journal:
Tech Coloproctol

Publication Year: 2020

DOI:
10.1007/s10151-020-02262-1

PMCID:
PMC7429543

PMID:
32564236

Journal Information

Full Title: Tech Coloproctol

Abbreviation: Tech Coloproctol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflicts of interest. Interim findings were presented as an oral presentation at the Association of Coloproctology of Great Britain and Ireland, Birmingham, UK, July 2018."

Evidence found in paper:

"Funding This study was funded and supported by the Chief Scientist Office (CZH/4/986) www.cso.scot.nhs.uk"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025